Zopiclone
Brand names: Zimovane
Zopiclone is a short-acting cyclopyrrolone ("Z-drug") hypnotic used for the short-term treatment of insomnia; this page concerns its use in older people, in whom a reduced dose is appropriate.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It enhances GABA-mediated inhibitory neurotransmission by binding at the benzodiazepine site of the GABA-A receptor, promoting sleep onset and continuity.
Prescribing in practice
- In older patients the risk of daytime sedation, confusion, falls and fractures is markedly increased, so use the lowest effective dose for the shortest possible period and review the need promptly.
- Tolerance and dependence develop with continued use, so prescribe for short courses only and avoid abrupt withdrawal after prolonged treatment.
- Effects are potentiated by alcohol and other CNS depressants including opioids, and impairment may accumulate where hepatic or renal function is reduced.
Monitoring
No routine laboratory monitoring is required, but reassess sleep benefit, daytime functioning, falls risk and ongoing need at each review.
Counselling the patient
- Take immediately before bed and only when a full night's sleep is possible, as it can cause next-day drowsiness.
- Do not drink alcohol with this medicine and take care with driving or tasks needing alertness.
- It is intended for short-term use only; speak to your prescriber before stopping if you have taken it regularly.
Evidence & guidelines
NICE guidance recommends Z-drugs only for short-term management of insomnia, and prescribing-safety advice emphasises lower doses and caution in older adults because of falls and confusion.
Reference: NICE CG49 (Insomnia); AGS Beers Criteria 2023; STOPP/START v3; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5